Date created

Celesio completes the acquisition of Bupa Home Healthcare

Celesio, a leading healthcare services company, has today announced the completion of its agreement with Bupa to purchase Bupa Home Healthcare, a clinical home healthcare provider. This follows Competition and Markets Authority (CMA) approval on 28th June.

Download Press release (PDF 166 KB)

The addition of Bupa Home Healthcare to Celesio UK complements existing services and strengthens the company’s national healthcare infrastructure, enabling patients to benefit from greater flexibility and more choice.

Bupa Home Healthcare provides clinical care in patients’ homes for a number of conditions including those that require specialty medicines such as Intestinal Failure and Lysosomal Storage Disorder, Cancer, Multiple Sclerosis and Rheumatoid Arthritis. The company has a national nursing team and its own aseptic manufacturing facilities. Around 1,000 employees are based across the UK.

About Celesio – and

Celesio UK is a leading provider of integrated healthcare services to the NHS specialising in medicines, pharmaceutical care and primary care patient services.

With almost 21,000 employees, more than 1,550 community pharmacies, a UK-wide logistics network and dispensing in excess of 150 million items a year, Celesio UK works in partnership with the NHS, community pharmacies and medicines manufacturers to help UK citizens live longer, healthier and more positive lives. Celesio provides customers, the NHS and patients with high levels of service, value, efficiency and innovation.

Celesio UK comprises LloydsPharmacy, AAH Pharmaceuticals, Evolution Homecare, LloydsPharmacy Online Doctor and Betterlife.

Celesio UK is part of Celesio Group; a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors. The proactive and preventive approach ensures that patients receive the products and support that they require for optimum care. 

With strong brands and about 32,000 employees, the group is active in 13 European countries (thereof with own operations in ten countries; Celesio manages operations in two countries and participates in a joint venture in one country). Every day, the company serves over 2 million customers – at more than 1,900 pharmacies of its own, at about 300 managed pharmacies and at over 4,500 participants in the brand partnership schemes. With 107 wholesale branches in Europe, Celesio supplies more than 50,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products.

McKesson Corporation, San Francisco, USA, is the majority shareholder in Celesio AG. The company acquired more than 75 percent of Celesio AG shares in February 2014. McKesson provides solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services.

About Bupa Home Healthcare

Bupa Home Healthcare is a leading provider of high quality home healthcare services supporting over 35,000 patients across the UK. It works in partnership with the NHS, pharmaceutical industry and private medical insurers to support patients with a range of conditions. Bupa Home Healthcare employs approximately 1000 people who work across the UK.

About Bupa

Bupa’s purpose is longer, healthier, happier lives. As a leading global health and care company, Bupa offers health insurance, medical subscription schemes and other health and care funding products; it runs care homes and retirement villages, primary care, diagnostic and wellness centres, hospitals and dental clinics. It also provides workplace health services, health assessments and long-term condition management services.

Bupa employs almost 80,000 people (as of 2014 year end), principally in the UK, Australia, Spain, Poland, New Zealand and Chile, as well as Saudi Arabia, Hong Kong, India, Thailand and the USA.

For more information, visit 

Press contact

Marc Binder, Director Group Communications
Marc Binder
Senior Vice President Group Communications
+49 711 5001-380
Rainer Berghausen, Head of Group External Communications
Rainer Berghausen
Head of Group External Communications
+49 711 5001-549